News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News PCR London Valves 2023 Acute Decompensated Aortic Stenosis: Time for an Urgent TAVI Pathway? Shelley Wood November 20, 2023
News Conference News PCR London Valves 2022 Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry Shelley Wood November 28, 2022
News Conference News PCR London Valves 2022 Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains Shelley Wood November 28, 2022
News Conference News PCR London Valves 2021 ‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI Michael O'Riordan November 25, 2021
News Conference News PCR London Valves 2021 Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry Shelley Wood November 24, 2021
News Conference News PCR London Valves 2019 Two Small Series Support Role for Cerebral Protection in TAVR Michael O'Riordan November 18, 2019
News Conference News PCR London Valves 2018 No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication Shelley Wood September 12, 2018
News Conference News PCR London Valves 2017 As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging Shelley Wood September 26, 2017
News Conference News PCR London Valves 2016 TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients Shelley Wood September 20, 2016
News Conference News PCR London Valves 2016 Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies Shelley Wood September 19, 2016